Moderna’s initial Phase 3 data shows its COVID-19 vaccine is up to 94.5% effective
By SONY SALZMAN, ABC News(NEW YORK) -- In another promising medical development, the biotechnology company Moderna has announced its COVID-19 vaccine could be up to 94.5% effective.The news comes a week after Pfizer announced its vaccine could be... Read More.
